|
2024-12-16 |
2024-12-13 |
PS
Planned sale
|
Hutson Nancy J
Non-Executive Director
|
7,000
-7.5%
7.54
USD 52,780
|
7,000
-7.5%
|
7.54
|
USD 52,780
|
|
|
2024-06-25 |
2024-06-24 |
S
Sale
|
McKee Amy E
Non-Executive Director
|
8,600
-23.6%
6.32
USD 54,352
|
8,600
-23.6%
|
6.32
|
USD 54,352
|
|
|
2024-06-17 |
2024-06-17 |
S
Sale
|
SANDERS MACHELLE
Non-Executive Director
|
4,689
-14.5%
6.00
USD 28,134
|
4,689
-14.5%
|
6.00
|
USD 28,134
|
|
|
2024-06-14 |
2024-06-14 |
S
Sale
|
HEGGIE THERESA
Non-Executive Director
|
6,698
-11.2%
6.11
USD 40,925
|
6,698
-11.2%
|
6.11
|
USD 40,925
|
|
|
2024-05-31 |
2024-05-30 |
B
Purchase
|
LEVIN ALAN G
Non-Executive Director
|
7,861
+21.2%
6.36
USD 49,996
|
7,861
+21.2%
|
6.36
|
USD 49,996
|
|
|
2024-05-29 |
2024-05-24 |
B
Purchase
|
ASELAGE STEVE
Non-Executive Director
|
2,500
+inf%
6.40
USD 16,000
|
2,500
+inf%
|
6.40
|
USD 16,000
|
|
|
2024-05-22 |
2024-05-20 |
B
Purchase
|
Hutson Nancy J
Non-Executive Director
|
5,000
+6.1%
6.38
USD 31,900
|
5,000
+6.1%
|
6.38
|
USD 31,900
|
|
|
2024-05-22 |
2024-05-20 |
B
Purchase
|
MILANO VINCENT
Non-Executive Director
|
15,000
+28.8%
6.25
USD 93,750
|
15,000
+28.8%
|
6.25
|
USD 93,750
|
|
|
2024-05-22 |
2024-05-20 |
B
Purchase
|
MILANO VINCENT
Non-Executive Director
|
15,000
+28.8%
6.25
USD 93,750
|
15,000
+28.8%
|
6.25
|
USD 93,750
|
|
|
2024-05-15 |
2024-05-14 |
B
Purchase
|
Thackray Helen M.
Chief R&D Officer
Officer
|
30,000
+12.4%
5.86
USD 175,800
|
30,000
+12.4%
|
5.86
|
USD 175,800
|
|
|
2024-05-15 |
2024-05-14 |
B
Purchase
|
Doyle Anthony
Chief Financial Officer
Officer
|
36,300
+15.8%
5.57
USD 202,191
|
36,300
+15.8%
|
5.57
|
USD 202,191
|
|
|
2024-05-15 |
2024-05-13 |
B
Purchase
|
Barnes Alane P
Chief Legal Officer
Officer
|
5,000
+1.7%
5.53
USD 27,650
|
5,000
+1.7%
|
5.53
|
USD 27,650
|
|
|
2024-05-15 |
2024-05-13 |
B
Purchase
|
Stonehouse Jon P
President & CEO
Executive Director
|
30,000
+2.7%
5.55
USD 166,500
|
30,000
+2.7%
|
5.55
|
USD 166,500
|
|
|
2024-05-15 |
2024-05-13 |
B
Purchase
|
Gayer Charles K
Chief Commercial Officer
Officer
|
30,000
+10.8%
5.47
USD 164,100
|
30,000
+10.8%
|
5.47
|
USD 164,100
|
|
|
2024-05-15 |
2024-05-13 |
B
Purchase
|
Galson Steven K
Non-Executive Director
|
21,940
+74.1%
5.49
USD 120,451
|
21,940
+74.1%
|
5.49
|
USD 120,451
|
|
|
2023-06-15 |
2023-06-15 |
S
Sale
|
SANDERS MACHELLE
Non-Executive Director
|
4,000
-13.5%
7.98
USD 31,920
|
4,000
-13.5%
|
7.98
|
USD 31,920
|
|
|
2023-06-15 |
2023-06-14 |
S
Sale
|
Hutson Nancy J
Non-Executive Director
|
12,866
-13.6%
8.04
USD 103,443
|
12,866
-13.6%
|
8.04
|
USD 103,443
|
|
|
2023-04-05 |
2023-04-03 |
PS
Planned sale
|
Thackray Helen M.
Chief R&D Officer
Officer
|
7,000
-3.3%
8.29
USD 58,030
|
7,000
-3.3%
|
8.29
|
USD 58,030
|
|
|
2023-02-02 |
2023-02-01 |
PS
Planned sale
|
Stonehouse Jon P
President & CEO
Executive Director
|
100,000
-9.0%
10.38
USD 1,038,000
|
100,000
-9.0%
|
10.38
|
USD 1,038,000
|
|
|
2022-12-19 |
2022-12-15 |
PS
Planned sale
|
Thackray Helen M.
Chief R&D Officer
Officer
|
3,125
-2.3%
10.89
USD 34,031
|
3,125
-2.3%
|
10.89
|
USD 34,031
|
|
|
2022-12-19 |
2022-12-15 |
PS
Planned sale
|
Stonehouse Jon P
President & CEO
Executive Director
|
14,100
-1.6%
10.90
USD 153,690
|
14,100
-1.6%
|
10.90
|
USD 153,690
|
|
|
2022-12-19 |
2022-12-15 |
PS
Planned sale
|
Gayer Charles K
Chief Commercial Officer
Officer
|
6,100
-2.8%
10.90
USD 66,490
|
6,100
-2.8%
|
10.90
|
USD 66,490
|
|
|
2022-12-19 |
2022-12-15 |
PS
Planned sale
|
Jones Michael L
Exec. Director, Finance - PAO
Officer
|
445
-4.0%
10.90
USD 4,851
|
445
-4.0%
|
10.90
|
USD 4,851
|
|
|
2022-12-19 |
2022-12-15 |
PS
Planned sale
|
Barnes Alane P
Chief Legal Officer
Officer
|
4,175
-2.1%
10.88
USD 45,424
|
4,175
-2.1%
|
10.88
|
USD 45,424
|
|
|
2022-12-19 |
2022-12-15 |
PS
Planned sale
|
Doyle Anthony
Chief Financial Officer
Officer
|
5,700
-3.4%
10.90
USD 62,130
|
5,700
-3.4%
|
10.90
|
USD 62,130
|
|
|
2022-12-02 |
2022-12-02 |
PS
Planned sale
|
Stonehouse Jon P
President & CEO
Executive Director
|
82,656
-8.4%
12.80
USD 1,057,997
|
82,656
-8.4%
|
12.80
|
USD 1,057,997
|
|
|
2022-12-02 |
2022-12-01 |
PS
Planned sale
|
Stonehouse Jon P
President & CEO
Executive Director
|
214,917
-19.2%
13.00
USD 2,793,921
|
214,917
-19.2%
|
13.00
|
USD 2,793,921
|
|
|
2022-12-02 |
2022-12-01 |
S
Sale
|
Jones Michael L
Exec. Director, Finance - PAO
Officer
|
8,600
-43.4%
13.01
USD 111,886
|
8,600
-43.4%
|
13.01
|
USD 111,886
|
|
|
2022-11-16 |
2022-11-14 |
S
Sale
|
Babu Yarlagadda S
Chief Discovery Officer
Officer
|
31,515
-9.5%
13.88
USD 437,428
|
31,515
-9.5%
|
13.88
|
USD 437,428
|
|
|
2022-04-20 |
2022-04-18 |
PS
Planned sale
|
ABERCROMBIE GEORGE B
Non-Executive Director
|
5,000
-100.0%
11.04
USD 55,200
|
5,000
-100.0%
|
11.04
|
USD 55,200
|
|
|
2022-04-04 |
2022-04-01 |
PS
Planned sale
|
Thackray Helen M.
Chief R&D Officer
Officer
|
7,600
-5.3%
16.20
USD 123,120
|
7,600
-5.3%
|
16.20
|
USD 123,120
|
|
|
2022-03-14 |
2022-03-10 |
S
Sale
|
Sheridan William P
Chief Medical Officer
Officer
|
1,400
-3.6%
17.64
USD 24,696
|
1,400
-3.6%
|
17.64
|
USD 24,696
|
|
|
2022-03-14 |
2022-03-10 |
S
Sale
|
Sheridan William P
Chief Medical Officer
Officer
|
159,739
-80.2%
16.87
USD 2,694,797
|
159,739
-80.2%
|
16.87
|
USD 2,694,797
|
|
|
2022-03-09 |
2022-03-07 |
S
Sale
|
Babu Yarlagadda S
Chief Discovery Officer
Officer
|
20,000
-8.0%
17.16
USD 343,200
|
20,000
-8.0%
|
17.16
|
USD 343,200
|
|
|
2022-03-03 |
2022-03-01 |
S
Sale
|
Jones Michael L
Exec. Director, Finance - PAO
Officer
|
2,300
-17.0%
17.20
USD 39,560
|
2,300
-17.0%
|
17.20
|
USD 39,560
|
|
|
2022-02-16 |
2022-02-15 |
PS
Planned sale
|
ABERCROMBIE GEORGE B
Non-Executive Director
|
5,000
-100.0%
18.50
USD 92,500
|
5,000
-100.0%
|
18.50
|
USD 92,500
|
|
|
2022-01-13 |
2022-01-11 |
PS
Planned sale
|
Stonehouse Jon P
President & CEO
Executive Director
|
184,000
-16.9%
15.04
USD 2,767,360
|
184,000
-16.9%
|
15.04
|
USD 2,767,360
|
|
|
2021-12-09 |
2021-12-07 |
S
Sale
|
Babu Yarlagadda S
Chief Discovery Officer
Officer
|
30,100
-12.3%
12.20
USD 367,220
|
30,100
-12.3%
|
12.20
|
USD 367,220
|
|
|
2021-11-24 |
2021-11-24 |
B
Purchase
|
MILANO VINCENT
Non-Executive Director
|
7,500
+75.0%
12.19
USD 91,425
|
7,500
+75.0%
|
12.19
|
USD 91,425
|
|
|
2021-11-24 |
2021-11-23 |
B
Purchase
|
Doyle Anthony
Chief Financial Officer
Officer
|
35,258
+60.3%
12.48
USD 440,020
|
35,258
+60.3%
|
12.48
|
USD 440,020
|
|
|
2021-11-17 |
2021-11-15 |
PS
Planned sale
|
ABERCROMBIE GEORGE B
Non-Executive Director
|
5,000
-100.0%
12.27
USD 61,350
|
5,000
-100.0%
|
12.27
|
USD 61,350
|
|
|
2021-10-19 |
2021-10-15 |
PS
Planned sale
|
Hutson Nancy J
Non-Executive Director
|
105,000
-61.7%
15.40
USD 1,617,000
|
105,000
-61.7%
|
15.40
|
USD 1,617,000
|
|
|
2021-09-17 |
2021-09-15 |
PS
Planned sale
|
ABERCROMBIE GEORGE B
Non-Executive Director
|
5,000
-100.0%
15.06
USD 75,300
|
5,000
-100.0%
|
15.06
|
USD 75,300
|
|
|
2021-09-14 |
2021-09-10 |
S
Sale
|
ABERCROMBIE GEORGE B
Non-Executive Director
|
74,000
-100.0%
15.09
USD 1,116,660
|
74,000
-100.0%
|
15.09
|
USD 1,116,660
|
|
|
2021-06-14 |
2021-06-10 |
PS
Planned sale
|
Hutson Nancy J
Non-Executive Director
|
23,333
-26.4%
16.86
USD 393,394
|
23,333
-26.4%
|
16.86
|
USD 393,394
|
|
|
2021-06-01 |
2021-05-28 |
PS
Planned sale
|
Sheridan William P
Chief Medical Officer
Officer
|
91,814
-86.4%
15.02
USD 1,379,046
|
91,814
-86.4%
|
15.02
|
USD 1,379,046
|
|
|
2021-06-01 |
2021-05-27 |
PS
Planned sale
|
Sheridan William P
Chief Medical Officer
Officer
|
71,759
-83.2%
15.00
USD 1,076,385
|
71,759
-83.2%
|
15.00
|
USD 1,076,385
|
|
|
2021-05-26 |
2021-05-24 |
PS
Planned sale
|
ABERCROMBIE GEORGE B
Non-Executive Director
|
6,667
-69.0%
13.90
USD 92,671
|
6,667
-69.0%
|
13.90
|
USD 92,671
|
|
|
2021-05-13 |
2021-05-11 |
S
Sale
|
Barnes Alane P
Chief Legal Officer
Officer
|
102,780
-48.2%
12.04
USD 1,237,471
|
102,780
-48.2%
|
12.04
|
USD 1,237,471
|
|
|
2021-02-24 |
2021-02-22 |
PS
Planned sale
|
Sheridan William P
Senior VP - CMO
Officer
|
41,250
-78.2%
11.57
USD 477,263
|
41,250
-78.2%
|
11.57
|
USD 477,263
|
|
|
2020-12-17 |
2020-12-15 |
PS
Planned sale
|
Stonehouse Jon P
President & CEO
Executive Director
|
134,278
-14.6%
8.32
USD 1,117,193
|
134,278
-14.6%
|
8.32
|
USD 1,117,193
|
|
|
2020-12-15 |
2020-12-11 |
PS
Planned sale
|
Barnes Alane P
Senior VP, Chief Legal Officer
Officer
|
13,741
-11.3%
7.96
USD 109,378
|
13,741
-11.3%
|
7.96
|
USD 109,378
|
|
|
2020-12-08 |
2020-12-04 |
PS
Planned sale
|
Barnes Alane P
Senior VP, Chief Legal Officer
Officer
|
13,741
-11.3%
6.23
USD 85,606
|
13,741
-11.3%
|
6.23
|
USD 85,606
|
|
|
2020-08-12 |
2020-08-11 |
B
Purchase
|
Doyle Anthony
Chief Financial Officer
Officer
|
54,000
+inf%
4.08
USD 220,320
|
54,000
+inf%
|
4.08
|
USD 220,320
|
|
|
2019-11-18 |
2019-11-18 |
B
Purchase
|
Sniecinski Megan
Chief Business Officer
Officer
|
45,000
+inf%
1.45
USD 65,250
|
45,000
+inf%
|
1.45
|
USD 65,250
|
|
|
2019-11-18 |
2019-11-18 |
B
Purchase
|
ASELAGE STEVE
Non-Executive Director
|
15,000
+224.8%
1.45
USD 21,750
|
15,000
+224.8%
|
1.45
|
USD 21,750
|
|
|
2019-11-18 |
2019-11-18 |
B
Purchase
|
Stonehouse Jon P
President & CEO
Executive Director
|
50,000
+6.9%
1.45
USD 72,500
|
50,000
+6.9%
|
1.45
|
USD 72,500
|
|
|
2019-11-18 |
2019-11-18 |
B
Purchase
|
Hutson Nancy J
Non-Executive Director
|
10,000
+23.2%
1.45
USD 14,500
|
10,000
+23.2%
|
1.45
|
USD 14,500
|
|
|
2019-11-18 |
2019-11-18 |
B
Purchase
|
Babu Yarlagadda S
Senior VP - Drug Discovery
Officer
|
25,000
+19.1%
1.45
USD 36,250
|
25,000
+19.1%
|
1.45
|
USD 36,250
|
|
|
2019-11-18 |
2019-11-18 |
B
Purchase
|
LEE KENNETH B JR
Non-Executive Director
|
5,000
+48.8%
1.45
USD 7,250
|
5,000
+48.8%
|
1.45
|
USD 7,250
|
|
|
2019-11-18 |
2019-11-18 |
B
Purchase
|
Barnes Alane P
Senior VP, Chief Legal Officer
Officer
|
20,000
+24.4%
1.45
USD 29,000
|
20,000
+24.4%
|
1.45
|
USD 29,000
|
|
|
2019-11-18 |
2019-11-18 |
B
Purchase
|
HEGGIE THERESA
Non-Executive Director
|
5,000
+299.0%
1.45
USD 7,250
|
5,000
+299.0%
|
1.45
|
USD 7,250
|
|
|
2019-11-18 |
2019-11-18 |
B
Purchase
|
INGRAM ROBERT ALEXANDER
Non-Executive Director
|
20,000
+71.2%
1.45
USD 29,000
|
20,000
+71.2%
|
1.45
|
USD 29,000
|
|
|
2019-05-24 |
2019-05-22 |
B
Purchase
|
ASELAGE STEVE
Non-Executive Director
|
3,000
+150.0%
3.57
USD 10,710
|
3,000
+150.0%
|
3.57
|
USD 10,710
|
|
|
2019-05-20 |
2019-05-17 |
PS
Planned sale
|
STAAB THOMAS R II
Senior Vice President and CFO
Officer
|
2,500
-2.0%
7.45
USD 18,625
|
2,500
-2.0%
|
7.45
|
USD 18,625
|
|
|
2019-05-20 |
2019-05-16 |
PS
Planned sale
|
STAAB THOMAS R II
Senior Vice President and CFO
Officer
|
7,250
-5.4%
7.72
USD 55,970
|
7,250
-5.4%
|
7.72
|
USD 55,970
|
|
|
2019-05-16 |
2019-05-15 |
PS
Planned sale
|
STAAB THOMAS R II
Senior Vice President and CFO
Officer
|
7,250
-5.3%
7.92
USD 57,420
|
7,250
-5.3%
|
7.92
|
USD 57,420
|
|
|
2019-05-16 |
2019-05-14 |
PS
Planned sale
|
STAAB THOMAS R II
Senior Vice President and CFO
Officer
|
4,500
-3.3%
7.62
USD 34,290
|
4,500
-3.3%
|
7.62
|
USD 34,290
|
|
|
2019-05-13 |
2019-05-13 |
PS
Planned sale
|
STAAB THOMAS R II
Senior Vice President and CFO
Officer
|
9,750
-6.8%
7.76
USD 75,660
|
9,750
-6.8%
|
7.76
|
USD 75,660
|
|
|
2019-05-13 |
2019-05-09 |
PS
Planned sale
|
STAAB THOMAS R II
Senior Vice President and CFO
Officer
|
9,750
-6.8%
7.63
USD 74,393
|
9,750
-6.8%
|
7.63
|
USD 74,393
|
|
|
2019-05-06 |
2019-05-06 |
PS
Planned sale
|
STAAB THOMAS R II
Senior Vice President and CFO
Officer
|
9,000
-6.4%
7.75
USD 69,750
|
9,000
-6.4%
|
7.75
|
USD 69,750
|
|
|
2019-05-06 |
2019-05-02 |
PS
Planned sale
|
STAAB THOMAS R II
Senior Vice President and CFO
Officer
|
7,750
-5.5%
7.30
USD 56,575
|
7,750
-5.5%
|
7.30
|
USD 56,575
|
|
|
2019-04-08 |
2019-04-04 |
PS
Planned sale
|
STAAB THOMAS R II
Senior Vice President and CFO
|
7,500
-5.4%
8.81
USD 66,075
|
7,500
-5.4%
|
8.81
|
USD 66,075
|
|
|
2019-03-14 |
2019-03-12 |
B
Purchase
|
ASELAGE STEVE
Non-Executive Director
|
2,000
+inf%
8.30
USD 16,600
|
2,000
+inf%
|
8.30
|
USD 16,600
|
|
|
2019-01-30 |
2019-01-28 |
PS
Planned sale
|
STAAB THOMAS R II
Senior Vice President and CFO
Officer
|
5,000
-3.7%
9.85
USD 49,250
|
5,000
-3.7%
|
9.85
|
USD 49,250
|
|
